PMS30 - COST ANALYSIS FOR DIFFERENT ANTI-RHEUMATOID BIOLOGICAL TREATMENTS AFTER FAILURE OF CONVENTIONAL DMARDS IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA
Abstract
Authors
L. Al Jawaheri H. AL-Mudaiheem M. Khalil H. Mohammed A. Ibrahim I. Anan M. Omair